Acadia Healthcare (NASDAQ:ACHC) Now Covered by Guggenheim

Guggenheim started coverage on shares of Acadia Healthcare (NASDAQ:ACHC) in a research report released on Wednesday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $36.00 target price on the stock.

A number of other equities research analysts have also recently issued reports on the stock. Mizuho reduced their target price on shares of Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a research report on Tuesday, March 25th. Barclays cut Acadia Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $43.00 to $35.00 in a report on Friday, February 28th. Cantor Fitzgerald restated a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. KeyCorp dropped their target price on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday, March 3rd. Finally, TD Cowen decreased their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $50.39.

Acadia Healthcare Stock Performance

Shares of ACHC traded down $2.19 during trading hours on Wednesday, hitting $26.91. The company had a trading volume of 702,961 shares, compared to its average volume of 1,930,046. The business has a fifty day moving average of $33.96 and a 200-day moving average of $41.87. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market cap of $2.50 billion, a price-to-earnings ratio of 8.76, a PEG ratio of 1.46 and a beta of 1.13. Acadia Healthcare has a 12 month low of $25.41 and a 12 month high of $82.40.

Hedge Funds Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the business. Verition Fund Management LLC acquired a new stake in Acadia Healthcare in the third quarter worth $382,000. Quantinno Capital Management LP increased its position in Acadia Healthcare by 153.0% in the 3rd quarter. Quantinno Capital Management LP now owns 7,974 shares of the company’s stock valued at $506,000 after buying an additional 4,822 shares in the last quarter. State Street Corp raised its stake in Acadia Healthcare by 3.5% during the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after buying an additional 95,613 shares during the period. Orion Portfolio Solutions LLC increased its holdings in shares of Acadia Healthcare by 12.5% during the third quarter. Orion Portfolio Solutions LLC now owns 18,166 shares of the company’s stock valued at $1,152,000 after acquiring an additional 2,013 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in Acadia Healthcare by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after purchasing an additional 14,197 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.